Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
JANX on Nasdaq
Avalon Ventures XI, L.P. - trading volume in the past year for Janux Therapeutics, Inc.
Holdings reported by Avalon Ventures XI, L.P. for Janux Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
3.22M |
$148M |
$46.13 |
Sep 10, 2024 |
By Avalon BioVentures SPV I, L.P. |
|
|
Common Stock |
3.02M |
$142M |
$47.00 |
Sep 12, 2024 |
By Avalon BioVentures SPV I, LP |
|
|
Common Stock |
2.96M |
$139M |
$47.00 |
Sep 12, 2024 |
Direct |
|
|
Common Stock |
573K |
$26.9M |
$47.00 |
Sep 12, 2024 |
By Avalon BioVentures I, LP |
|
|
Stock Option (right to buy) |
8.07K |
|
|
Sep 9, 2024 |
Direct |
Common Stock |
|
Transactions reported by Avalon Ventures XI, L.P. for Janux Therapeutics, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.